AUDUBON, Pa., 06. Aug. 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), ein führendes Unternehmen im Bereich muskuloskelettaler Technologie, gab heute seine Finanzergebnisse für das am 30. Juni 2026 beendete zweite Quartal bekannt.
NEW YORK, June 1, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Globus Medical, Inc. (NYSE: GMED) on behalf of the company's shareholders. The investigation seeks to determine whether Globus Medical's directors breached their fiduciary duties in connection with recent corporate actions.
Globus Medical NYSE: GMED reported a strong start to 2026, with first-quarter revenue and earnings rising sharply as the company cited continued momentum in U.S. spine, margin expansion and contributions from its Nevro acquisition.
AUDUBON, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced its financial results for the first quarter ended March 31, 2026.